These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22483057)

  • 1. Why P is not perfect.
    Chopra V; Hayward RA
    Am J Med; 2012 Jun; 125(6):e1-2. PubMed ID: 22483057
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin for the primary prevention of adverse cardiovascular events.
    Estes K; Thomure J
    Crit Care Nurs Q; 2008; 31(4):324-39. PubMed ID: 18815480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for the primary prevention of vascular events?
    Morgan G
    Public Health; 2009 Dec; 123(12):787-8. PubMed ID: 19914670
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin for people with diabetes: a misleading inference in a recent meta-analysis?
    Martin-Carrillo P; Añino A; Pinar O; Fernandez I; Saenz A; Ausejo M
    Diabetes Res Clin Pract; 2010 Oct; 90(1):e1; author reply e2. PubMed ID: 20675004
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.
    Hopper I; Billah B; Skiba M; Krum H
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):813-23. PubMed ID: 21878448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAA- a further step towards a moratorium for aspirin in the primary prevention.
    Minar E
    Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 10. Is a formal statistical analysis always necessary?
    Woehlck H
    Anesth Analg; 2011 Jun; 112(6):1268-9. PubMed ID: 21613193
    [No Abstract]   [Full Text] [Related]  

  • 11. [Logical structure of problem-oriented clinical record. A combined Popper-Bayes approach].
    Scandellari C
    Ann Ital Med Int; 2002; 17(2):130-1. PubMed ID: 12154807
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene-environment interactions: how many false positives?
    Matullo G; Berwick M; Vineis P
    J Natl Cancer Inst; 2005 Apr; 97(8):550-1. PubMed ID: 15840871
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
    Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials.
    Soejima H; Morimoto T; Saito Y; Ogawa H
    Thromb Haemost; 2010 Dec; 104(6):1085-8. PubMed ID: 20941462
    [No Abstract]   [Full Text] [Related]  

  • 16. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
    Waltering A; Hemkens L; Florack C
    Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.